518 related articles for article (PubMed ID: 11861842)
1. Efficient and selective gene transfer into primary human brain tumors by using single-chain antibody-targeted adenoviral vectors with native tropism abolished.
van Beusechem VW; Grill J; Mastenbroek DC; Wickham TJ; Roelvink PW; Haisma HJ; Lamfers ML; Dirven CM; Pinedo HM; Gerritsen WR
J Virol; 2002 Mar; 76(6):2753-62. PubMed ID: 11861842
[TBL] [Abstract][Full Text] [Related]
2. Combined targeting of adenoviruses to integrins and epidermal growth factor receptors increases gene transfer into primary glioma cells and spheroids.
Grill J; Van Beusechem VW; Van Der Valk P; Dirven CM; Leonhart A; Pherai DS; Haisma HJ; Pinedo HM; Curiel DT; Gerritsen WR
Clin Cancer Res; 2001 Mar; 7(3):641-50. PubMed ID: 11297260
[TBL] [Abstract][Full Text] [Related]
3. Selective gene transfer into primary human gastric tumors using epithelial cell adhesion molecule-targeted adenoviral vectors with ablated native tropism.
Heideman DA; van Beusechem VW; Offerhaus GJ; Wickham TJ; Roelvink PW; Craanen ME; Pinedo HM; Meijer CJ; Gerritsen WR
Hum Gene Ther; 2002 Sep; 13(14):1677-85. PubMed ID: 12396621
[TBL] [Abstract][Full Text] [Related]
4. Retargeting of adenoviral infection to melanoma: combining genetic ablation of native tropism with a recombinant bispecific single-chain diabody (scDb) adapter that binds to fiber knob and HMWMAA.
Nettelbeck DM; Rivera AA; Kupsch J; Dieckmann D; Douglas JT; Kontermann RE; Alemany R; Curiel DT
Int J Cancer; 2004 Jan; 108(1):136-45. PubMed ID: 14618628
[TBL] [Abstract][Full Text] [Related]
5. Effective gene transfer to human melanomas via integrin-targeted adenoviral vectors.
Nakamura T; Sato K; Hamada H
Hum Gene Ther; 2002 Mar; 13(5):613-26. PubMed ID: 11916485
[TBL] [Abstract][Full Text] [Related]
6. Tumor-specific gene transfer via an adenoviral vector targeted to the pan-carcinoma antigen EpCAM.
Haisma HJ; Pinedo HM; Rijswijk A; der Meulen-Muileman I; Sosnowski BA; Ying W; Beusechem VW; Tillman BW; Gerritsen WR; Curiel DT
Gene Ther; 1999 Aug; 6(8):1469-74. PubMed ID: 10467371
[TBL] [Abstract][Full Text] [Related]
7. Optimizing cardiovascular gene therapy: increased vascular gene transfer with modified adenoviral vectors.
Kibbe MR; Murdock A; Wickham T; Lizonova A; Kovesdi I; Nie S; Shears L; Billiar TR; Tzeng E
Arch Surg; 2000 Feb; 135(2):191-7. PubMed ID: 10668880
[TBL] [Abstract][Full Text] [Related]
8. Selective gene delivery toward gastric and esophageal adenocarcinoma cells via EpCAM-targeted adenoviral vectors.
Heideman DA; Snijders PJ; Craanen ME; Bloemena E; Meijer CJ; Meuwissen SG; van Beusechem VW; Pinedo HM; Curiel DT; Haisma HJ; Gerritsen WR
Cancer Gene Ther; 2001 May; 8(5):342-51. PubMed ID: 11477454
[TBL] [Abstract][Full Text] [Related]
9. Incorporation of Peptides Targeting EGFR and FGFR1 into the Adenoviral Fiber Knob Domain and Their Evaluation as Targeted Cancer Therapies.
Uusi-Kerttula H; Legut M; Davies J; Jones R; Hudson E; Hanna L; Stanton RJ; Chester JD; Parker AL
Hum Gene Ther; 2015 May; 26(5):320-9. PubMed ID: 25919378
[TBL] [Abstract][Full Text] [Related]
10. Effective high-capacity gutless adenoviral vectors mediate transgene expression in human glioma cells.
Candolfi M; Curtin JF; Xiong WD; Kroeger KM; Liu C; Rentsendorj A; Agadjanian H; Medina-Kauwe L; Palmer D; Ng P; Lowenstein PR; Castro MG
Mol Ther; 2006 Sep; 14(3):371-81. PubMed ID: 16798098
[TBL] [Abstract][Full Text] [Related]
11. Liposome-complexed adenoviral gene transfer in cancer cells expressing various levels of coxsackievirus and adenovirus receptor.
Lee EM; Hong SH; Lee YJ; Kang YH; Choi KC; Choi SH; Kim IH; Lim SJ
J Cancer Res Clin Oncol; 2004 Mar; 130(3):169-77. PubMed ID: 14677059
[TBL] [Abstract][Full Text] [Related]
12. CAR- or alphav integrin-binding ablated adenovirus vectors, but not fiber-modified vectors containing RGD peptide, do not change the systemic gene transfer properties in mice.
Mizuguchi H; Koizumi N; Hosono T; Ishii-Watabe A; Uchida E; Utoguchi N; Watanabe Y; Hayakawa T
Gene Ther; 2002 Jun; 9(12):769-76. PubMed ID: 12040458
[TBL] [Abstract][Full Text] [Related]
13. In vivo hepatic adenoviral gene delivery occurs independently of the coxsackievirus-adenovirus receptor.
Smith T; Idamakanti N; Kylefjord H; Rollence M; King L; Kaloss M; Kaleko M; Stevenson SC
Mol Ther; 2002 Jun; 5(6):770-9. PubMed ID: 12027562
[TBL] [Abstract][Full Text] [Related]
14. Efficient and Highly Specific Gene Transfer Using Mutated Lentiviral Vectors Redirected with Bispecific Antibodies.
Parker CL; Jacobs TM; Huckaby JT; Harit D; Lai SK
mBio; 2020 Jan; 11(1):. PubMed ID: 31964730
[TBL] [Abstract][Full Text] [Related]
15. Targeting adenoviral vectors by using the extracellular domain of the coxsackie-adenovirus receptor: improved potency via trimerization.
Kim J; Smith T; Idamakanti N; Mulgrew K; Kaloss M; Kylefjord H; Ryan PC; Kaleko M; Stevenson SC
J Virol; 2002 Feb; 76(4):1892-903. PubMed ID: 11799184
[TBL] [Abstract][Full Text] [Related]
16. Differential susceptibility of primary and established human glioma cells to adenovirus infection: targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer.
Miller CR; Buchsbaum DJ; Reynolds PN; Douglas JT; Gillespie GY; Mayo MS; Raben D; Curiel DT
Cancer Res; 1998 Dec; 58(24):5738-48. PubMed ID: 9865732
[TBL] [Abstract][Full Text] [Related]
17. Tissue-targeted in vivo gene transfer coupled with histone deacetylase inhibitor depsipeptide (FK228) enhances adenoviral infection in rat renal cancer allograft model systems.
Kobayashi M; Okada T; Murakami T; Ozawa K; Kobayashi E; Morita T
Urology; 2007 Dec; 70(6):1230-6. PubMed ID: 18158067
[TBL] [Abstract][Full Text] [Related]
18. Sstr2A: a relevant target for the delivery of genes into human glioblastoma cells using fiber-modified adenoviral vectors.
Lécolle K; Bégard S; Caillierez R; Demeyer D; Grellier E; Loyens A; Csaba Z; Beauvillain JC; D'Halluin JC; Baroncini M; Lejeune JP; Sharif A; Prévot V; Dournaud P; Buée L; Colin M
Gene Ther; 2013 Mar; 20(3):283-97. PubMed ID: 22592599
[TBL] [Abstract][Full Text] [Related]
19. Peptide targeting of adenoviral vectors to augment tumor gene transfer.
Ballard EN; Trinh VT; Hogg RT; Gerard RD
Cancer Gene Ther; 2012 Jul; 19(7):476-88. PubMed ID: 22595794
[TBL] [Abstract][Full Text] [Related]
20. Targeting EGFR with metabolically biotinylated fiber-mosaic adenovirus.
Pereboeva L; Komarova S; Roth J; Ponnazhagan S; Curiel DT
Gene Ther; 2007 Apr; 14(8):627-37. PubMed ID: 17251987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
